Same Indication

Osimertinib vs Rosuvastatin

Osimertinib vs Rosuvastatin: Overview

This comparison examines the pharmacological differences between Osimertinib and Rosuvastatin.

Mechanism of Action

Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

Rosuvastatin: Competitive inhibitor of HMG-CoA reductase.

Pharmacokinetics

Half-life: Osimertinib β€” 48 hours; Rosuvastatin β€” 19 hours.

Chemical Properties

Molecular Formula: Osimertinib β€” C28H33N7O2; Rosuvastatin β€” C22H28FN3O6S.

Molecular Weight: Osimertinib β€” 499.6050 g/mol; Rosuvastatin β€” 481.5390 g/mol.

Type: Osimertinib β€” Small molecule; Rosuvastatin β€” Small molecule.